Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure

Arthritis and Rheumatism

Volumn 62, Issue 5, 2010, Pages 1280-1289

  Ewert, Patricia ^a   Aguilera, Sergio ^b   Alliende, Cecilia ^a   Kwon, Yoon Jeoung ^a   Albornoz, Amelina ^a   Molina, Claudio ^c   Urzúa, Ulises ^a   Quest, Andrew F G ^d   Olea, Nancy ^a   Pérez, Paola ^a   Castro, Isabel ^a   Barrera, María José ^a   Romo, Rafael ^e   Hermoso, Marcela ^a   Leyton, Cecilia ^a   González, María Julieta ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Hospital Exequiel González Cortés   (Chile)

^c UNIVERSIDAD MAYOR   (Chile)

^d UNIVERSITY OF CHILE   (Chile)

^e Santa Maria Clinic   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

CLAUDIN 1; CLAUDIN 3; CLAUDIN 4; CYTOKINE; GAMMA INTERFERON; OCCLUDIN; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SALIVARY GLAND; SJOEGREN SYNDROME; TIGHT JUNCTION; TRANSMISSION ELECTRON MICROSCOPY;

ADULT; AGED; BIOPSY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERFERON-GAMMA; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; PHOSPHOPROTEINS; RNA, MESSENGER; SALIVARY GLANDS; SJOGREN'S SYNDROME; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77951711146     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27362     Document Type: Article

References (40)

1. Anaya JM, Talal N. Sjögren's syndrome comes of age. Semin Arthritis Rheum 1999;28:355-359
2. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994;152:5532-5539 (Pubitemid 24153003)
3. Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol 1995;34:326-333
4. Fox PC, Grisius MM, Bermudez DK, Sun D. Cytokine mRNA expression in labial salivary glands and cytokine secretion in parotid saliva in Sjögren's syndrome. Adv Exp Med Biol 1998;438:909-915 (Pubitemid 28303839)
5. Jonsson R, Gordon TP, Konttinen YT. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome. Curr Rheumatol Rep 2003;5:311-316
6. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjö-gren's disease. J Clin Pathol 1968;21:656-660
7. Daniels TE, Whitcher JP. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca: analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheum 1994;37:869-877 (Pubitemid 24184539)
8. Tarpley TM Jr, Anderson LG, White CL. Minor salivary gland involvement in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 1974;37:64-74.
9. Laine M, Virtanen I, Salo T, Konttinen YT. Segment-specific but pathologic laminin isoform profiles in human labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2004;50:3968-3973 (Pubitemid 39643945)
10. Goicovich E, Molina C, Perez P, Aguilera S, Fernandez J, Olea N, et al. Enhanced degradation of proteins of the basal lamina and stroma by matrix metalloproteinases from the salivary glands of Sjögren's syndrome patients: correlation with reduced structural integrity of acini and ducts. Arthritis Rheum 2003;48:2573-2584 (Pubitemid 37129434)
11. Alliende C, Kwon YJ, Brito M, Molina C, Aguilera S, Perez P, et al. Reduced sulfation of muc5b is linked to xerostomia in patients with Sjögren syndrome. Ann Rheum Dis 2008;67:1480-1487
12. Delporte C. Aquaporins in secretory glands and their role in Sjögren's syndrome. Handb Exp Pharmacol 2009;190:185-201.
13. Paris L, Tonutti L, Vannini C, Bazzoni G. Structural organization of the tight junctions. Biochim Biophys Acta 2008;1778:646-659
14. Martin-Belmonte F, Rodriguez-Fraticelli AE. Chapter 3: acquisition of membrane polarity in epithelial tube formation patterns, signaling pathways, molecular mechanisms, and disease. Int Rev Cell Mol Biol 2009;274:129-182
15. Mitic LL, Van Itallie CM, Anderson JM. Molecular physiology and pathophysiology of tight junctions I. Tight junction structure and function: lessons from mutant animals and proteins. Am J Physiol Gastrointest Liver Physiol 2000;279:G250-4.
16. Flynn AN, Itani OA, Moninger TO, Welsh MJ. Acute regulation of tight junction ion selectivity in human airway epithelia. Proc Natl Acad Sci U S A 2009;106:3591-3596
17. Cereijido M, Contreras RG, Flores-Benitez D, Flores-Maldonado C, Larre I, Ruiz A, et al. New diseases derived or associated with the tight junction. Arch Med Res 2007;38:465-478 (Pubitemid 46873811)
18. Visser J, Rozing J, Sapone A, Lammers K, Fasano A. Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms. Ann N Y Acad Sci 2009;1165:195-205.
19. Utech M, Ivanov AI, Samarin SN, Bruewer M, Turner JR, Mrsny RJ, et al. Mechanism of IFN-γ-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane. Mol Biol Cell 2005;16:5040-5052 (Pubitemid 41416480)
20. Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 2000;119:1740-1744
21. Vermeer PD, Denker J, Estin M, Moninger TO, Keshavjee S, Karp P, et al. MMP9 modulates tight junction integrity and cell viability in human airway epithelia. Am J Physiol Lung Cell Mol Physiol 2009;296:L751-62.
22. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol 2008;130:55-70.
23. Baker OJ, Camden JM, Redman RS, Jones JE, Seye CI, Erb L, et al. Proinflammatory cytokines tumor necrosis factor-α and interferon-γ alter tight junction structure and function in the rat parotid gland Par-C10 cell line. Am J Physiol Cell Physiol 2008;295:C1191-201.
24. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558
25. Daniels TE. Labial salivary gland biopsy in Sjögren's syndrome: assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984;27:147-156
26. Perez P, Kwon YJ, Alliende C, Leyton L, Aguilera S, Molina C, et al. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Arthritis Rheum 2005;52:2751-2760 (Pubitemid 41369103)
27. Kwon YJ, Perez P, Aguilera S, Molina C, Leyton L, Alliende C, et al. Involvement of specific laminins and nidogens in the active remodeling of the basal lamina of labial salivary glands from patients with Sjögren's syndrome. Arthritis Rheum 2006;54:3465-3475 (Pubitemid 44737158)
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254
29. Perez P, Anaya JM, Aguilera S, Urzua U, Munroe D, Molina C, et al. Gene expression and chromosomal location for susceptibility to Sjögren's syndrome. J Autoimmun 2009;33:99-108.
30. Luft JH. Improvements in epoxy resin embedding methods. J Biophys Biochem Cytol 1961;9:409-414
31. Youakim A, Ahdieh M. Interferon-γ decreases barrier function in T84 cells by reducing ZO-1 levels and disrupting apical actin. Am J Physiol 1999;276:G1279-88.
32. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, et al. TNF-α-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am J Physiol Gastrointest Liver Physiol 2004;286:G367-76.
33. Li J, Sherman-Baust CA, Tsai-Turton M, Bristow RE, Roden RB, Morin PJ. Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer. BMC Cancer 2009;9:244.
34. Manoussakis MN, Kapsogeorgou EK. The role of epithelial cells in the pathogenesis of Sjögren's syndrome. Clin Rev Allergy Immunol 2007;32:225-230 (Pubitemid 350242568)
35. Mankertz J, Tavalali S, Schmitz H, Mankertz A, Riecken EO, Fromm M, et al. Expression from the human occludin promoter is affected by tumor necrosis factor α and interferon γ. J Cell Sci 2000;113:2085-2090 (Pubitemid 30386512)
36. Takehara M, Nishimura T, Mima S, Hoshino T, Mizushima T. Effect of claudin expression on paracellular permeability, migration and invasion of colonic cancer cells. Biol Pharm Bull 2009;32:825-831
37. Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 1999;96:511-516 (Pubitemid 29061239)
38. Umeda K, Ikenouchi J, Katahira-Tayama S, Furuse K, Sasaki H, Nakayama M, et al. ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation. Cell 2006;126:741-754 (Pubitemid 44233624)
39. Van Itallie C, Rahner C, Anderson JM. Regulated expression of claudin-4 decreases paracellular conductance through a selective decrease in sodium permeability. J Clin Invest 2001;107:1319-1327 (Pubitemid 32494549)
40. Kawedia JD, Nieman ML, Boivin GP, Melvin JE, Kikuchi K, Hand AR, et al. Interaction between transcellular and paracellular water transport pathways through Aquaporin 5 and the tight junction complex. Proc Natl Acad Sci U S A 2007;104:3621-3626 (Pubitemid 46364208)